Head to head
| Vials (LillyDirect) | Pens (pharmacy) | |
|---|---|---|
| Cost | $349–$499 / month | ~$1,060 / month list |
| Doses offered | 2.5, 5, 7.5, 10 mg | 2.5 through 15 mg |
| Delivery | Draw with syringe, self-inject | Prefilled autoinjector, one click |
| How you buy it | Direct from Lilly, self-pay | Pharmacy, insurance or cash |
| Insurance | Not used — cash program | Billable, copay $25–$100 when covered |
| Prescription | Required | Required |
Why the price gap exists
Pens move through the traditional pharmacy supply chain — wholesalers, pharmacies, and pharmacy benefit managers each taking a cut, with rebates negotiated against a high list price. Vials skip that entirely: Lilly ships directly to the patient at a set cash price.
The program launched in 2024 while compounded tirzepatide was still widely available at $200–$500/month. After the FDA ended most compounding in 2025, vials absorbed that market — and for many patients they now cost less than the compounded product did.
Which should you choose?
Choose vials if…
- You are uninsured, or your plan excludes weight loss drugs
- Your appeal was denied and cash-pay is the path
- You are at or below the 10 mg dose
- You are comfortable drawing a dose with a syringe
Choose pens if…
- Insurance covers Zepbound with a real copay
- You need 12.5 mg or 15 mg
- Needle handling or dose-drawing makes you uneasy
- You travel often and want the simplest routine
Covered by insurance? Pens are almost always cheaper. Paying cash? Vials cut the bill roughly in half. Before switching, confirm your copay — a $25 savings-card copay beats any cash program.
Frequently asked questions
Are Zepbound vials the same medication as the pens?
Yes. Both contain tirzepatide, made by Eli Lilly to the same FDA-approved specification. The difference is packaging and delivery: pens are prefilled single-dose autoinjectors, vials are single-dose glass containers you draw into a syringe yourself. Same drug, same effect.
Why are vials so much cheaper?
They are sold directly by Lilly through LillyDirect for cash-paying patients, bypassing pharmacy benefit managers and their rebate structure. Lilly launched the vial program in 2024 partly to compete with compounded tirzepatide; when the FDA ended most compounding in 2025, vials became the main low-cost legitimate option at $349–$499/month versus roughly $1,060 list for pens.
Which doses do vials come in?
Vials are offered in the lower and mid dose range — 2.5 mg, 5 mg, 7.5 mg, and 10 mg. The highest doses (12.5 mg and 15 mg) are pen-only. If you titrate to the top of the range, you will likely move to pens or discuss options with your prescriber.
Is drawing from a vial hard?
It is an extra step, not a hard one. You draw the full single-dose contents into a syringe and inject subcutaneously — the same technique millions of insulin users perform daily. Your prescriber or pharmacist should walk you through it, and Lilly provides instructions. If needle handling makes you anxious, pens are worth the premium.
Can I use insurance with vials?
Generally no. LillyDirect vial pricing is a self-pay program — you are choosing to pay cash instead of running the claim through your plan. If your insurance covers Zepbound with a low copay, the pens through your pharmacy benefit are usually cheaper than $349/month. Vials win when you are uninsured, excluded, or denied.
Do vials require a prescription?
Yes. Every form of tirzepatide is prescription-only. LillyDirect requires a valid prescription from a licensed provider before it will ship, whether you get that prescription from your own clinic or through a telehealth provider.
Related reading
Educational content, not medical advice. Prices change and program terms vary — confirm current pricing with LillyDirect and your prescriber. GLPFinders does not prescribe, sell, or dispense medications.